Literature DB >> 8386737

Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.

K C Meyer1, J Zimmerman.   

Abstract

Proteolytic enzymes derived from inflammatory cells or Pseudomonas aeruginosa may destroy lung matrix in cystic fibrosis (CF). Antielastases appear to be overwhelmed by large amounts of free neutrophil elastase (NE) activity in lower respiratory tract secretions, and proteolytic or oxidant stress is thought to account for such deficiency. The purpose of this study was to measure NE and myeloperoxidase activity in bronchoalveolar lavage fluid (BAL) from patients with CF and to correlate levels of these mediators with the degree of airflow obstruction and density of P. aeruginosa in BAL. We measured NE activity in BAL fluid from 14 patients with respiratory exacerbations of CF. NE complexed with alpha 1-antiprotease in peripheral blood was measured in 13 of the 14 patients subjected to BAL and in 21 additional patients who did not undergo BAL. Because oxidants generated by myeloperoxidase may contribute to increased elastase activity via inactivation of alpha 1-antiprotease, myeloperoxidase activity in BAL was also measured. We found that elastase activity in BAL correlated significantly with the ratio of forced expiratory volume in 1 second to forced vital capacity (FEV1/FVC ratio) (r = -0.80, p < 0.001) and FEV1 percent predicted (r = -0.62, p = 0.02). Myeloperoxidase activity also significantly correlated with airflow obstruction (FEV1/FVC ratio, r = -0.70, p = 0.005; FEV1 percent predicted, r = -0.52, p = 0.05). However, the degree of airflow obstruction, NE activity, myeloperoxidase activity, or total neutrophils in BAL did not correlate with the density of P. aeruginosa (CFU/ml) or total pathogen burden in BAL fluid.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8386737

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  17 in total

1.  IL-17-induced cytokine release in human bronchial epithelial cells in vitro: role of mitogen-activated protein (MAP) kinases.

Authors:  M Laan; J Lötvall; K F Chung; A Lindén
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients.

Authors:  Dieter Worlitzsch; Robert Tarran; Martina Ulrich; Ute Schwab; Aynur Cekici; Keith C Meyer; Peter Birrer; Gabriel Bellon; Jürgen Berger; Tilo Weiss; Konrad Botzenhart; James R Yankaskas; Scott Randell; Richard C Boucher; Gerd Döring
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.

Authors:  Hajime Fujimoto; Esteban C Gabazza; Osamu Taguchi; Yoichi Nishii; Hiroki Nakahara; Nelson E Bruno; Corina N D'Alessandro-Gabazza; Michael Kasper; Yutaka Yano; Mariko Nagashima; John Morser; George J Broze; Koji Suzuki; Yukihiko Adachi
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 4.  Role of free radicals in the pathogenesis of cystic fibrosis.

Authors:  R K Brown; F J Kelly
Journal:  Thorax       Date:  1994-08       Impact factor: 9.139

5.  Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs.

Authors:  Megha Makam; Daisy Diaz; Julie Laval; Yael Gernez; Carol K Conrad; Colleen E Dunn; Zoe A Davies; Richard B Moss; Leonore A Herzenberg; Leonard A Herzenberg; Rabindra Tirouvanziam
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-17       Impact factor: 11.205

6.  Nebulized thiocyanate improves lung infection outcomes in mice.

Authors:  J D Chandler; E Min; J Huang; D P Nichols; B J Day
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

7.  Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways.

Authors:  Rabindra Tirouvanziam; Yael Gernez; Carol K Conrad; Richard B Moss; Iris Schrijver; Colleen E Dunn; Zoe A Davies; Leonore A Herzenberg; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

Review 8.  Sputum biomarkers of inflammation in cystic fibrosis lung disease.

Authors:  Scott D Sagel; James F Chmiel; Michael W Konstan
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

9.  A role for CFTR in the elevation of glutathione levels in the lung by oral glutathione administration.

Authors:  Chirag Kariya; Heather Leitner; Elysia Min; Christiaan van Heeckeren; Anna van Heeckeren; Brian J Day
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-03-16       Impact factor: 5.464

10.  Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways.

Authors:  O Prause; S Bozinovski; G P Anderson; A Lindén
Journal:  Thorax       Date:  2004-04       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.